Resultados de la búsqueda 451-460 of 2694 for Inhibition
... inhibitors and are refractory to or intolerant to other available therapies. A Study of Proton Radiation Divided into Fewer Doses for Low Risk Prostate ...
... inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the patient is post renal transplantation ...
... inhibitors sirolimus or everolimus as part of their clinical care. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now.
The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L) ...
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. Journal of Clinical Pathology. 2019; doi:10.1136/jclinpath-2019-205822. Sim B, et al. Risk ...
... inhibitor. In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with ...
The purpose of this study is: To assess the efficacy of treatment with checkpoint inhibitors (Pembrolizumab or Nivolumab) in metastatic gastric and esophageal ...
... inhibitors and are refractory to or intolerant to other available therapies. Numeración de páginas Estudios clínicos. AnteriorPágina anterior · Ir a página 11 ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?